INVESTOR RELATIONS CENTER

China Shineway Pharmaceutical Group Limited

News Detail

EQS-News News vom 28.09.2018

Shineway was selected into the pilot list of Yunnan Province's TCM formula granules research


EQS-News / 28/09/2018 / 10:52 UTC+8

Shineway was selected into the pilot list of Yunnan Province's TCM formula granules research

Yunnan Shineway Spirin Pharmaceutical, a wholly-owned subsidiary of Shineway, was selected into the pilot list of Yunnan Province's TCM formula granules research, and received financial support from Yunnan Provincial Project Fund. Shineway's production facilities in the Chuxiong Prefecture of Yunnan Province is also expected to be completed by October this year to add another 1 billion bags (grams) of TCM formula granules capacity. These latest developments signify that Shineway's venturing into the Yunnan Province's TCM formula granules market has officially commenced.

Other Shineway news:

1. Shineway has recently entered into strategic cooperation agreements with a number of online clinics and online retail pharmacies, including "WeDoctor", an online healthcare service provider; "Ehaoyao.com", the online pharmacy of Jointown Pharmaceutical; and "1 Pharmacy", the online pharmacy of 111 Inc., to position its "internet + medicine" industry value chain.

For more information, please contact Mr. Randy Hung, Director of Investor Relations via email randyhung@shineway.com.hk

 



Document: http://n.eqs.com/c/fncls.ssp?u=MCMRJCSAAR
Document title: Shineway was selected into the pilot list of Yunnan Province's TCM formula granules research

28/09/2018 Dissemination of a Marketing Press Release, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Media archive at www.todayir.com

show this
Diese Inhalte werden Ihnen präsentiert von der .